Abstract:BACKGROUND Aldosterone has been implicated in a variety of organ fibroses, but its role and mechanism in liver fibrosis remain unclear. METHODS Rat primary hepatic stellate cells (HSCs) were isolated, cultured, and characterized. HSCs were incubated with aldosterone (10(-6) M) for 4 h, 8 h, 12 h, 24 h, and 48 h, after which TGF-β1 (transforming growth factor beta 1) expression was measured by real-time PCR. Rat HSCs were treated with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M), and the expressions of PAI-1 (plasminogen activator inhibitor-1) and TGF-β1 were determined by measuring mRNA and protein. HSCs were incubated in groups containing aldosterone (10(-6) M), spironolactone (10(-5) M), both aldosterone and spironolactone, or neither aldosterone nor spironolactone (control), after which mRNA and protein expression of PAI-1 and TGF-β1 were measured. Collagen I expression was detected by immunohistochemical analysis of supernatants of the aldosterone (10(-6) M), TGF-β1, and aldosterone plus TGF-β1 groups. SMAD expression was detected in rat HSC control, HSC plus aldosterone (10(-6) M), HSC plus TGF-β1, and HSC plus aldosterone plus TGF-β1 groups. RESULTS HSCs were incubated with aldosterone for 4 h, 8 h, 12 h, 24 h, and 48 h after which TGF-β1 expression was measured. We found that TGF-β1 expression increased in a time dependent manner and reached a peak at 24 h. The expression of TGF-β1 in groups treated with aldosterone for 4 h, 8 h, 12 h, and 24 h was significantly different from the control group (P < 0.01). No significant difference was seen in TGF-β1 expression between the groups treated with aldosterone for 24 h and 48 h (P > 0.05). Compared with the control group, TGF-β1 expression was significantly increased after incubation with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M) (P < 0.01). There were significant differences in the expression of TGF-β1 between 10(-6) M and 10(-7) M aldosterone treatment groups (P < 0.01). Compared with the control group, the expression of PAI-1 was significantly increased after incubation with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M) (P < 0.01). PAI-1 expression was increased in the aldosterone, spironolactone, and aldosterone plus spironolactone groups. The expression of PAI-1 was significantly enhanced in the aldosterone and aldosterone plus spironolactone groups compared with the control group (P < 0.01). There was a marked enhancement of collagen I expression in the aldosterone, TGF-β1, and aldosterone plus TGF-β1 groups (P < 0.05). Collagen I expressions in the aldosterone and TGF-β1 groups were significantly different from the aldosterone plus TGF-β1 group (P < 0.01). Compared with the control group, SMAD expression was markedly elevated in the aldosterone, TGF-β1, and aldosterone plus TGF-β1 groups (P < 0.05). The expression of SMAD was significantly increased in the aldosterone plus TGF-β1 group compared with the aldosterone group (P < 0.01). CONCLUSION This study demonstrated that aldosterone promoted HSC activation and the expression of TGF-β1, PAI-1, and collagen in hepatic fibrosis progression and that spironolactone administration partially reversed the effects. The aldosterone promotional effect on hepatic fibrosis was partially mediated by TGF-β1.

Effects of artesunate and ceramide on cell proliferation, collagen generated and MMP13 expression in hepatic stellate cells

Effects of Artesunate on Cell Proliferation, Collaging Generating and KLF6 Expression in Hepatic Stellate Cells

Impact of artesunate on the expression and secretion of transforming growth factor-β1 of primary rat hepatic stellate cells

[Effects of Artesunate on Hepatic Fibrosis and Its Mechanism].

Effects of artesunate on MMPs expression in hepatic fibrosis of rats

Turtle Carapace Decoction and Drug Containing Serum on Hepatic Stellate Cells

Effect of artesunate on rat liver fibrogenesis in vitro and in vivo

Progress in Research on the Effects of Artesunate on the Molecular Mechanism of Liver Fibrosis

Effects of artesunate on proliferation of HSCs

[Effect of anti-fibrosis compound contained serum on procollagen Type I and IV, matrix metalloproteinase and its tissue inhibitor-1 gene expression in HSC-LI90 cell line]

Effect of Artesunate on Akt/GSK-3β/β-catenin Signal Pathway in Human Hepatic Stellate Cells

Artesunate ameliorates hepatic fibrosis induced by bovine serum albumin in rats through regulating matrix metalloproteinases.

[Effects of Bone Morphogenic Proteins-7 on Production of Collagen from Hepatocytes and Hepatic Stellate Cells During Liver Fibrosis].

Effects of Artesunate on Proliferation and Apoptosis of Hepatic Stellate Cells

Effect of Bone Marrow Mesenchymal Stem Cells and Artesunate on Liver Fibrosis

Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells

Effect of Aldosterone and Its Antagonist on the Expression of PAI-1 and TGF-β1 in Rat Hepatic Stellate Cells.

Effects of all-trans retinioc acid on expressions of COL1α2,MMP-2,TIMP-1, and signaling pathway in TGF-β1-simulated rat hepatic stellate cells

In Vitro Study on the Role and Mechanism of Interferon Α-1B in Regulating the Inhibition of Protein Kinase Cεand Cα on Fibrosis of Hepatic Stellate Cells

[Effects of Cordyceps Acid and Cordycepin on the Inflammatory and Fibrogenic Response of Hepatic Stellate Cells].

Effect of interfering RNA targeting high mobility group box chromosomal protein 1 on the biological characters of hepatic stellate cells